Valuation: Bioneer Corporation

Market Cap 211B 156M 136M 129M 117M 220M 14.91B 221M 1.54B 597M 7.62B 584M 571M 24.48B P/E 2024
-23.6x
P/E 2025 -117x
Enterprise Value 225B 166M 145M 137M 125M 234M 15.89B 236M 1.64B 637M 8.12B 622M 609M 26.09B EV / Sales 2024
1.59x
EV / Sales 2025 1.04x
Free-Float
82.04%
Yield 2024 *
-
Yield 2025 -
1 day-0.97%
1 week-7.26%
Current month-6.94%
1 month-3.08%
3 months+31.51%
6 months-29.30%
Current year-35.84%
1 week 8,150
Extreme 8150
8,790
1 month 8,070
Extreme 8070
11,300
Current year 5,470
Extreme 5470
14,210
1 year 5,470
Extreme 5470
15,640
3 years 5,470
Extreme 5470
39,100
5 years 5,470
Extreme 5470
77,600
10 years 4,355
Extreme 4355
98,800
Manager TitleAgeSince
Chief Executive Officer 64 01/08/1992
Corporate Officer/Principal 62 28/03/2024
Corporate Officer/Principal 51 31/03/2025
Director TitleAgeSince
Director/Board Member 64 18/02/2011
Director/Board Member 62 01/05/1997
Director/Board Member 63 01/02/2000
Date Insider Type Main position Quantity % Market Cap. Importance
6/12/25 A Exercice

Director

2,625 0.0102%
3/3/25 A Buy

Chief Executive Officer

3,000 0.0116%
1/22/25 A Buy 1,579 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
-0.97%-7.26%-41.40%-76.15% 156M
-3.30%+1.50%+57.79%+99.14% 72.26B
+1.25%-3.01%+37.83%+87.66% 60.24B
+2.12%+5.26%+35.69%+23.40% 27.73B
-3.06%-1.81%-14.01%+357.24% 25.73B
-0.75%+2.56%+0.45%-3.28% 24.75B
+0.40%+0.75%+23.72%-11.33% 20.74B
-1.70%-2.12%+150.24%+326.97% 15.06B
+0.36%-0.34%+48.98%+167.40% 14.41B
+0.21%+1.17%-3.95%+512.06% 14.23B
Average -0.54%-0.71%+29.53%+148.31% 27.53B
Weighted average by Cap. -0.77%+0.30%+38.12%+132.87%

Financials

2024 2025
Net sales 294B 217M 190M 179M 164M 306M 20.76B 308M 2.15B 832M 10.6B 813M 796M 34.08B 330B 243M 213M 202M 184M 344M 23.31B 346M 2.41B 934M 11.91B 913M 893M 38.27B
Net income -20.58B -15.16M -13.31M -12.57M -11.45M -21.44M -1.45B -21.59M -150M -58.25M -742M -56.93M -55.7M -2.39B -2.81B -2.07M -1.82M -1.72M -1.57M -2.93M -199M -2.95M -20.55M -7.96M -101M -7.78M -7.61M -326M
Net Debt -20.54B -15.13M -13.28M -12.54M -11.43M -21.39M -1.45B -21.54M -150M -58.12M -741M -56.81M -55.58M -2.38B 13.9B 10.24M 8.98M 8.49M 7.73M 14.48M 981M 14.58M 102M 39.33M 501M 38.44M 37.61M 1.61B
Logo Bioneer Corporation
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and ribonucleic acid interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Company’s products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The Company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.
Employees
383
Date Price Change Volume
23/09/26 ₩8,180.00 -0.97% 116,250
22/09/26 ₩8,260.00 -3.17% 318,987
21/09/26 ₩8,530.00 -3.29% 178,840
18/09/26 ₩8,820.00 -4.13% 677,622
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A064550 Stock